Valuation: Eckert & Ziegler SE

Market Cap 873M 999M 806M 742M 1.4B 96.2B 1.43B 9.63B 3.79B 47.11B 3.75B 3.67B 162B P/E 2026 *
16.6x
P/E 2027 * 15.5x
Enterprise Value 757M 867M 699M 644M 1.21B 83.45B 1.24B 8.35B 3.29B 40.87B 3.25B 3.18B 141B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.17x
Free-Float
67.36%
Yield 2026 *
1.4%
Yield 2027 * 1.43%
1 day-0.86%
1 week-7.65%
Current month-9.87%
1 month-8.50%
3 months-11.08%
6 months-15.42%
Current year-8.92%
1 week 13.85
Extreme 13.85
14.97
1 month 13.85
Extreme 13.85
15.88
Current year 13.49
Extreme 13.49
16.58
1 year 13.49
Extreme 13.49
22.87
3 years 9.69
Extreme 9.6867
23
5 years 9.69
Extreme 9.6867
47.07
10 years 1.63
Extreme 1.6276
47.07
Manager TitleAgeSince
Chief Executive Officer 59 2023-06-06
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Operating Officer 59 2024-12-31
Director TitleAgeSince
Chairman 57 2023-06-06
Director/Board Member 66 2013-12-31
Director/Board Member 58 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.86%-7.65% - - 999M
-1.46%+0.58%+18.67%-22.19% 17.27B
-6.27%-7.01%-0.84%+86.72% 1.57B
-4.71%-4.87%-31.71%-79.21% 1.19B
-4.06%+2.84%-28.35%-52.18% 644M
-7.46%-4.05%-40.62%-56.91% 532M
-1.95%-4.52%+45.72%-53.63% 445M
-1.26%+0.64%-54.33%-58.41% 382M
+7.76%+6.36%-19.65%-21.95% 364M
-3.29%+9.05%+45.26% - 331M
Average -2.36%+0.33%-7.32%-32.22% 2.52B
Weighted average by Cap. -2.01%+0.03%+11.05%-20.51%

Financials

2026 *2027 *
Net sales 322M 368M 297M 274M 516M 35.45B 527M 3.55B 1.4B 17.36B 1.38B 1.35B 59.76B 344M 394M 318M 293M 552M 37.96B 565M 3.8B 1.49B 18.59B 1.48B 1.45B 64B
Net income 52.28M 59.82M 48.24M 44.47M 83.81M 5.76B 85.67M 577M 227M 2.82B 225M 220M 9.71B 54.93M 62.86M 50.69M 46.73M 88.07M 6.05B 90.02M 606M 238M 2.96B 236M 231M 10.21B
Net Debt -116M -132M -107M -98.35M -185M -12.74B -189M -1.28B -502M -6.24B -497M -486M -21.48B -126M -144M -116M -107M -202M -13.89B -206M -1.39B -547M -6.8B -541M -530M -23.41B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,100
Date Price Change Volume
26-07-17 €13.88 -0.86% 214
26-07-16 €14.00 -2.64% 150
26-07-15 €14.38 -2.90% 100
26-07-14 €14.81 -1.07% 0
26-07-13 €14.97 -0.40% 600
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.95EUR
Average target price
22.10EUR
Spread / Average Target
+58.42%

Quarterly revenue - Rate of surprise